- Home
- NESR vs SEPN Comparison
NESR vs SEPN Comparison
Compare NESR & SEPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NESR
- SEPN
- Stock Information
- Founded
- NESR 2017
- SEPN 2022
- Country
- NESR United States
- SEPN United States
- Employees
- NESR N/A
- SEPN N/A
- Industry
- NESR
- SEPN
- Sector
- NESR
- SEPN
- Exchange
- NESR NYSE
- SEPN NYSE
- Market Cap
- NESR 597.0M
- SEPN 522.7M
- IPO Year
- NESR N/A
- SEPN 2024
- Fundamental
- Price
- NESR $6.42
- SEPN $13.88
- Analyst Decision
- NESR Strong Buy
- SEPN Strong Buy
- Analyst Count
- NESR 5
- SEPN 5
- Target Price
- NESR $14.20
- SEPN $26.75
- AVG Volume (30 Days)
- NESR 1.2M
- SEPN 307.9K
- Earning Date
- NESR 08-11-2025
- SEPN 08-15-2025
- Dividend Yield
- NESR N/A
- SEPN N/A
- EPS Growth
- NESR 214.19
- SEPN N/A
- EPS
- NESR 0.80
- SEPN N/A
- Revenue
- NESR $1,307,958,000.00
- SEPN $977,000.00
- Revenue This Year
- NESR $6.09
- SEPN $3,429.67
- Revenue Next Year
- NESR $8.33
- SEPN N/A
- P/E Ratio
- NESR $8.01
- SEPN N/A
- Revenue Growth
- NESR 11.45
- SEPN 108.76
- 52 Week Low
- NESR $5.20
- SEPN $4.17
- 52 Week High
- NESR $9.89
- SEPN $28.99
- Technical
- Relative Strength Index (RSI)
- NESR N/A
- SEPN N/A
- Support Level
- NESR N/A
- SEPN N/A
- Resistance Level
- NESR N/A
- SEPN N/A
- Average True Range (ATR)
- NESR 0.00
- SEPN 0.00
- MACD
- NESR 0.00
- SEPN 0.00
- Stochastic Oscillator
- NESR 0.00
- SEPN 0.00
About NESR NATIONAL ENERGY SVCS REUNITED CORP
National Energy Services Reunited Corp is a British Virgin Islands-based company engaged in providing products and services to the oil and gas industry in the Middle East and North Africa and the Asia Pacific regions. The company has two reportable segments: Production Services including coil tubing, stimulation, and pumping, nitrogen services, completions, pipelines, cementing, laboratory services and filtration services; and Drilling and Evaluation Services including drilling and workover rigs, rig services, services, and well-testing services among others. Revenues are majorly derived from production services of an oil or natural gas well. It derives maximum revenue from Production services segment.
About SEPN SEPTERNA INC
Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, GLP-1R, GIPR, and GCGR.